Literature DB >> 9788825

Increased expression of P-selectin on platelets is a risk factor for silent cerebral infarction in patients with atrial fibrillation: role of nitric oxide.

T Minamino1, M Kitakaze, S Sanada, H Asanuama, T Kurotobi, Y Koretsune, M Fukunami, T Kuzuya, N Hoki, M Hori.   

Abstract

BACKGROUND: Platelet activation and decreased levels of nitrite and nitrate (NOx), stable end products of nitric oxide (NO), are reported in patients with atrial fibrillation (AF). We examined the time-course changes in plasma NOx levels and the expression of P-selectin on platelets after the onset of AF in a canine model and determined whether these parameters could be risk factors for silent cerebral infarction in patients with AF. METHODS AND
RESULTS: AF was induced by rapid atrial pacing in the canine model of AF. Plasma NOx levels were significantly decreased and the levels of P-selectin on platelets and of neutrophil/platelet conjugates were significantly increased after the onset of AF in this model. The in vitro experiments demonstrated that the inhibition of NO synthesis increased the expression of P-selectin on platelets. Plasma NOx levels (19.7+/-2.4 versus 27.5+/-2.8 micromol/L) were significantly lower in 25 patients with AF compared with age- (+/-2 years) and sex-matched control subjects. Conversely, the levels of P-selectin on platelets (7.6+/-0.8% versus 4.8+/-0.7%) and of neutrophil/platelet conjugates (14.8+/-0.9% versus 8.1+/-0.6%) were significantly higher in patients with AF. Multiple regression analysis revealed that increased P-selectin on platelets and advanced age were associated with the number of foci of silent cerebral infarction.
CONCLUSIONS: An irregular heart rate that is characteristic of AF appeared to blunt NO synthesis. The increased expression of P-selectin on platelets associated with the reduced NO levels was a risk factor for silent cerebral infarction in patients with AF.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9788825     DOI: 10.1161/01.cir.98.17.1721

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  12 in total

Review 1.  Prevention of stroke in patients with high-risk atrial fibrillation.

Authors:  Richard A Bernstein; Rod Passman
Journal:  Curr Neurol Neurosci Rep       Date:  2010-01       Impact factor: 5.081

2.  Radiofrequency ablation reduces expression of SELF by upregulating the expression of microRNA-26a/b in the treatment of atrial fibrillation.

Authors:  Min Dai; Tao Jiang; Cai-Dong Luo; Wei Du; Min Wang; Qing-Yan Qiu; Hu Wang
Journal:  J Interv Card Electrophysiol       Date:  2022-07-21       Impact factor: 1.759

3.  Nitroprusside modulates pulmonary vein arrhythmogenic activity.

Authors:  Yung-Kuo Lin; Yen-Yu Lu; Yao-Chang Chen; Yi-Jen Chen; Shih-Ann Chen
Journal:  J Biomed Sci       Date:  2010-03-20       Impact factor: 8.410

Review 4.  Risk of "silent stroke" in patients older than 60 years: risk assessment and clinical perspectives.

Authors:  Jae-Sung Lim; Hyung-Min Kwon
Journal:  Clin Interv Aging       Date:  2010-09-07       Impact factor: 4.458

5.  Effect of physical exercise on platelet activity and the von-Willebrand-factor in patients with persistent lone atrial fibrillation.

Authors:  Andreas Goette; Mathias Weber; Uwe Lendeckel; Tobias Welte; Gerd Lutze; Helmut U Klein
Journal:  J Interv Card Electrophysiol       Date:  2004-04       Impact factor: 1.900

6.  Plasma Levels of Nitrites/Nitrates in Patients with Chronic Atrial Fibrillation are Increased after Electrical Restoration of Sinus Rhythm.

Authors:  Dragana Nikitovic; Evangelos A Zacharis; Emmanuel G Manios; Nikki E Malliaraki; Emmanuel M Kanoupakis; Katerina I Sfiridaki; Emmanuel I Skalidis; Andreas N Margioris; Panos E Vardas
Journal:  J Interv Card Electrophysiol       Date:  2002-10       Impact factor: 1.900

Review 7.  Lung ischemia-reperfusion injury: implications of oxidative stress and platelet-arteriolar wall interactions.

Authors:  Alexander V Ovechkin; David Lominadze; Kara C Sedoris; Tonya W Robinson; Suresh C Tyagi; Andrew M Roberts
Journal:  Arch Physiol Biochem       Date:  2007-02       Impact factor: 4.076

8.  Lysophosphatidic acid level and the incidence of silent brain infarction in patients with nonvalvular atrial fibrillation.

Authors:  Zhen-Guang Li; Zhan-Cai Yu; Yong-Peng Yu; Wei-Ping Ju; Dao-Zhen Wang; Xia Zhan; Xi-Juan Wu; Li Zhou
Journal:  Int J Mol Sci       Date:  2010-10-19       Impact factor: 5.923

9.  Angiotensin-Receptor Blocker, Angiotensin-Converting Enzyme Inhibitor, and Risks of Atrial Fibrillation: A Nationwide Cohort Study.

Authors:  Yu-Cheng Hsieh; Chen-Ying Hung; Cheng-Hung Li; Ying-Chieh Liao; Jin-Long Huang; Ching-Heng Lin; Tsu-Juey Wu
Journal:  Medicine (Baltimore)       Date:  2016-05       Impact factor: 1.889

10.  Standardization and reference ranges for whole blood platelet function measurements using a flow cytometric platelet activation test.

Authors:  Dana Huskens; Yaqiu Sang; Joke Konings; Lisa van der Vorm; Bas de Laat; Hilde Kelchtermans; Mark Roest
Journal:  PLoS One       Date:  2018-02-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.